LFCS CONSORTIUM - Key Persons
Job Titles:
- Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences
Chris Porter is Professor of Pharmaceutics at the Monash Institute of Pharmaceutical Sciences and Associate Dean (Research) of the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University, Melbourne. He completed his undergraduate and graduate studies at the University of Nottingham in the UK before moving to Australia and Monash in 1992. Subsequently, Chris' research program has focused on understanding and quantifying drug absorption, distribution and elimination profiles and on developing the models and techniques to probe these interactions. A major interest has been the issues and problems surrounding the absorption of poorly water soluble, highly lipophilic drugs and in particular the use of lipid based delivery systems to enhance oral bioavailability and stimulate lymphatic transport. In 2009 Chris was awarded the American Association of Pharmaceutical Scientists (AAPS) lipid based drug delivery outstanding research award in recognition of his efforts in this area. More recently, his interests have also expanded into the mechanisms of cellular transport of lipophilic drugs and the potential utility of dendrimers as drug delivery systems. Chris has published more than 100 peer reviewed papers and has received in excess of $6m in funding from both government and the commercial sector. He is a current member of the Editorial Boards of Pharmaceutical Research, the Journal of Pharmaceutical Sciences and the Journal of Pharmacy and Pharmacology.
Dr. Moss qualified as a pharmacist after receiving a BPharm from Nottingham University, UK. He was awarded a MSc in radiation biology from The University of Bath, UK and this was followed by a PhD in molecular biology also from the University of Bath.
He was appointed to the faculty of the School of Pharmacy and Pharmacology in 1972 and has remained a faculty member until the present time with a short interlude as a visiting scientist as Stanford University, California working in the Medical School.
His undergraduate teaching activities have included pharmaceutics, pharmaceutical microbiology and industrial pharmacy and he supervised 26 PhD students
He has been a member of a number of scientific and professional bodies and in 1995 was designated a Fellow of the Royal Pharmaceutical Society of Great Britian.
His publications number more than 40 full papers and a further 60 communications on topics including pharmaceutical stability, cellular repair of radiation damage, drug targetting, gene delivery and the formulation of poorly soluble drugs in lipid mixture.
In addition to his activities as a pharmaceutical scientist Dr. Moss has always been involved in teaching and research in relation to the application of computers in pharmacy. This has included teaching computer programming to undergraduate students and acting as the Director of PCCAL, the Pharmacy consortium for Computer Aided Learning.
In parallel with his academic career Dr. Moss founded CoAcS Ltd in 1994 and has acted as the Chairman and Managing director from the company's formation until the present time. CoAcS Ltd has two divisions, the software division has established itself as a world leader in the supply of computer applications to the pharmaceutical profession, and the pharmaceutical division has acted as consultants to major pharmaceutical industries in Europe and the Middle East.
Dr. Anette Müllertz is associate professor and is heading Bioneer:FARMA, Danish Drug Development Center, at the Faculty of Pharmaceutical Sciences University of Copenhagen (FARMA). She received her PhD degree in lipid nutrition at the Technical University of Denmark in 1991. She spend 8 years as a research scientist at Novo Nordisk A/S, Denmark, working on the development of structured lipids, digestive lipases and digestion models, among other projects. In 1998 she joined the Royal Danish School of Pharmacy, Copenhagen, Denmark, as an associate professor. She is heading the research group for poorly soluble drugs at the Department of Pharmaceutics and Analytical Chemistry, at what is now FARMA. Her area of research is biopharmaceutics and oral delivery of poorly soluble drugs, including development of oral lipid based drug delivery systems, in vitro lipolysis models, simulated intestinal fluids, physiologically relevant absorption models and lymphatic transport. She has more than 45 papers in international referred journals, most of them published during the last 5 years, as well as 6 book chapters. She has been/are supervising 18 PhD students and numerous master students. She was the winner of the 2005 AAPS Lipid Based Drug Delivery Award. Presently she is leading the Predicting Drug Absorption Consortium, sponsored by the Danish government and involving 5 pharmaceutical companies.
Job Titles:
- Senior Director, Pharmaceutical Sciences, Capsugel, Strasbourg, France
Hassan Benameur, Ph.D., is a Senior Director at Capsugel and brings over 20 year's expertise in conventional and advanced drug delivery development to frequently innovate in product design. Dr. Benameur joined Capsugel R&D in 2002, and currently leads the Pharmaceutical Sciences department within Capsugel with the objective to bring insightful science into innovative dosage forms, and to use drug delivery technology to maximize success and reduce attrition in product development, from pre-formulation to manufacturing using a systematic and rational approach. Dr. Benameur also evaluates and acquires new technologies using a unique methodology. Prior to joining Capsugel, Dr. Benameur held various positions in Pharmaceutical Research and Development within Therapeutica, SMB Galephar, and Gattefossé.
Dr. Benameur is a Chemical Engineer and holds a PhD in Pharmaceutical Sciences from the Free University of Belgium. He is also a lecturer at several academic and industrial symposia (US, Europe, China, Japan) and was presented the Academy of Pharmaceutical Science and Technology, Japan Award in 2005. Dr. Benameur is a member of several major scientific associations (AAPS, APGI BCRG, PSTJ and CRS) and scientific academies, and is also the author of 20 scientific publications and the inventor of over 15 patents.